Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 7/20 | 0.36 |
| ▸ | ACHE | P22303 | 8/20 | 0.34 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL2231643 | 0.87 | KCNH2 (0.35) | KCNH2ACHEGPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL927489 | 0.84 | KCNH2 (0.36) | KCNH2ACHEGPR3CA1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL64973 | 0.83 | GPR3 (0.38) | KCNH2ACHEGPR3CA1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL7145436 | 0.80 | GPR3 (0.37) | KCNH2ACHEGPR3CA1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL15667318 | 0.78 | KCNH2 (0.38) | KCNH2ACHEGPR3CA1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL28255383 | 0.76 | KCNH2 (0.37) | KCNH2ACHEGPR3CA1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL28705191 | 0.76 | KCNH2 (0.37) | KCNH2ACHEGPR3CA1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL29171769 | 0.76 | KCNH2 (0.37) | KCNH2ACHEGPR3CA1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL23430060 | 0.73 | CA1 (0.44) | KCNH2ACHEGPR3CA1CA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL25287606 | 0.73 | CA1 (0.44) | KCNH2ACHEGPR3CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040222401-A1 | Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors | XU KANG (US) | 2004-11-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040222401-A1 | Electrochemically stable onium salts and electrolytes containing such for electrochemical capacitors | VDAC2, VDAC1, HCN2 | KCNH2 86/4885ACHE 679/4885GPR3 4228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.